In contrast, a large prospective study in patients presenting with acute coronary syndrome showed that anti-PC IgM titers did not exhibit a significant relationship with cardiovascular outcomes such as myocardial infarction, stroke, or severe recurrent ischemia29. This evidence concerns the gene CD40LG and Stroke.